Comparative growth pattern of multi drug resistance versus susceptible isolates of Mycobacterium tuberculosis in mice lungs

Indian Journal of Medical Research

Volumn 130, Issue 1, 2009, Pages 58-62

  Dave, Sakshi ^a   Faujdar, Jaya ^a   Kumar, Praveen ^a   Gupta, P ^a   Das, Ram ^a   Parasher, Deepti ^a   Chauhan, D S ^a   Natrajan, M ^a   Gupta, U D ^a   Katoch, V M ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Aerosol infection; Growth pattern; Mice; Multi drug resistant (MDR); Mycobacterium tuberculosis

Indexed keywords

ARGININE; ETHAMBUTOL; ISONIAZID; KATG PROTEIN; LEUCINE; OFLOXACIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; SERINE; STREPTOMYCIN; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIUM ISOLATE; CONTROLLED STUDY; EXPERIMENTAL MOUSE; GROWTH RATE; LUNG TUBERCULOSIS; MISSENSE MUTATION; MOUSE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPECIES COMPARISON;

ANIMALS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 70349532815     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistanct tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
2. Rusch-Gerdes S. Epidemiology of resistant tuberculosis in Europe. Infection (Suppl 2) 1999; 27: S17-8.
3. Gupta UD, Katoch VM. Animal models of tuberculosis. Tuberculosis 2005; 85: 277-93.
4. Dannenberg AM Jr, Collins FM. Progressive pulmonary tuberculosis is not due to increasing number of viable bacilli in rabbits, mice and guinea pigs but is due to constant host response to mycobacterial products. Tuberculosis 2001; 81: 229-42.
5. Chackeraian A, Alt J, Perera V, Beher SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun 2002; 70: 6302-9.
6. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchinson DA, et al. Advances in techniques of testing mycobacterial drug sensitivity the use of sensitivity tests in tuberculosis control programme. Bull World Health Organ 1969; 41: 21-43.
7. Van Embden JDA, Cane MD, Cranford JT, Dale J, Eisenach KD, Gicwuel Hermans, et al. Strain identification of M. tuberculosis by DNA fingerprinting: Recommendation for a standardization of methodology. J Clin Microbiol 1993; 32: 406-9.
8. Siddqui N, Shamim M, Hussain S, Choudhary RK, Ahmed N, Prachee, et al. Molecular characterization of multidrug resistant isolates of M. tuberculosis from patients of North India. Antimicrob Agents Chemother 2002; 46: 443-50.
9. Fite GL, Cambre FJ, Turner MH. Procedures for demonstrating lepra bacilli in paraffin sections. Arch Pathol 1947; 43: 624-5.
10. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: 496-514.
11. Ramon Garcia S, Martin C, De Rossi, Edda, Ainsa JA. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. J Antimicrob Chemother 2007; 59: 544-7.
12. Telenti A, Marchesi F, Balz M, Bully F, Bohger EC, Bodmer T. Rapid identification of mycobacteria to species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-8.
13. Kapur V, Li LL, Iordanescu S, Hamarick MC, Wanger A, Kreiswirth BN, et al. Characterization by automated DNA sequencing of mutation in the gene (rpoB) encoding the RNA polymerase B subunit in rifampin resistant M. tuberculosis strains from NewYork city and Texas. J Clin Microbiol 1994; 32: 1095-8.
14. Mani C, Selvakumar N, Naraynan PR. Mutations in rpoB gene of multi drug resistant M. tuberculosis in clinical isolates from India. J Clin Microbiol 2001; 39: 2987-90.
15. Ramaswamy S, Musser J. Molecular genetic bases of antimicrobial agent resistance in M. tuberculosis: 1998 update. Tuber Lung Dis 1998; 79: 3-29.
16. Blanchard JS. Molecular mechanism of drug resistance in M. tuberculosis. Annu Rev Biochem 1996; 65: 215-39.
17. Zhang Y, Beate H, Allen B, Young D, Cole S. The catalase peroxidase gene and INH resistance of M. tuberculosis. Nature 1992; 358: 591-3.
18. Van doorn HR, Kuijper EJ, van der Ende A, Welten AG, van Soolingen D, de Haas PE, et al. The susceptibility of M. tuberculosis to isoniazid and Arg-->Leu mutation at codon463 of katG gene are not associated. J Clin Microbiol 2001; 39: 1591-4.
19. Didkinson JM, Mitchison DA. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev Respir Dis 1981; 123: 367-71.
20. Cohn ML, Kovitz C, Oda U, Middlebrook G. Studies on isoniazid and tubercle bacilli. The high growth requirements, catalase activities and pathogenic properties of isoniazid resislant mutants. Am Rev Tuber 1954; 70: 465-75.
21. Li Z, Kelly C, Collins F, Rouse DM. Expression of katG in M. tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis 1998; 177: 1030-5.
22. Medina E, North RJ. Resistance ranking of some common onbred mouse strain to M. tuberculosis relation to major hisocompatibility complex haplotype and Nramp genotype. Immunology 1998; 93: 2922-4.
23. North RJ, Ryan L, La Cource R, Mogues T, Goodrich MM. Growth rate in mice in an unreliable indicator of mycobacterial virulence as evidenced by a comparative study with CDC 1551 and two other strains of M. tuberculosis complex. Infect Immun 1999; 67: 5483-5.
24. Ordway DJ, Sonnerberg MG, Donahue SA, Belisk JT, Orme IM. Drug resistant strain of M. tuberculosis exhibit a range of virulence for mice. Infect Immun 1995; 63: 741-3.